Blueprint Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-781
| Closed | -$406K | – | 194 |
|
|
2024
Q4 | $406K | Sell |
781
-565
| -42% | -$294K | 0.06% | 141 |
|
|
2024
Q3 | $833K | Buy |
1,346
+181
| +16% | +$112K | 0.15% | 74 |
|
|
2024
Q2 | $644K | Sell |
1,165
-51
| -4% | -$28.2K | 0.14% | 68 |
|
|
2024
Q1 | $707K | Buy |
1,216
+784
| +181% | +$456K | 0.14% | 65 |
|
|
2023
Q4 | $229K | Buy |
+432
| New | +$229K | 0.06% | 124 |
|
|
2023
Q2 | – | Sell |
-1,260
| Closed | -$726K | – | 233 |
|
|
2023
Q1 | $726K | Buy |
1,260
+30
| +2% | +$17.3K | 0.17% | 81 |
|
|
2022
Q4 | $677K | Buy |
1,230
+82
| +7% | +$45.2K | 0.14% | 106 |
|
|
2022
Q3 | $582K | Buy |
1,148
+308
| +37% | +$156K | 0.16% | 74 |
|
|
2022
Q2 | $456K | Sell |
840
-4,816
| -85% | -$2.61M | 0.12% | 86 |
|
|
2022
Q1 | $3.34M | Buy |
5,656
+1,078
| +24% | +$637K | 0.86% | 29 |
|
|
2021
Q4 | $3.05M | Buy |
4,578
+1,772
| +63% | +$1.18M | 0.75% | 37 |
|
|
2021
Q3 | $1.6M | Buy |
2,806
+1,105
| +65% | +$631K | 0.8% | 27 |
|
|
2021
Q2 | $858K | Buy |
1,701
+232
| +16% | +$117K | 0.69% | 26 |
|
|
2021
Q1 | $670K | Buy |
1,469
+1,468
| +146,800% | +$670K | 0.52% | 28 |
|
|
2020
Q4 | $309 | Sell |
1
-663
| -100% | -$205K | 0.25% | 38 |
|
|
2020
Q3 | $309K | Buy |
+664
| New | +$309K | 0.24% | 42 |
|